A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Search:
Medline
CancerConsultants.com
Both
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.82-0.37 (-0.82%)
NVS$53.13-0.16 (-0.3%)
SNY$37.67-0.01 (-0.03%)
GSK$41.530.06 (0.14%)
click here

Home: Drug Pipeline   Print This Page 


Cancer Consultants Cancer Drug Pipeline



Skin Cancer
Drug Name Class Developer Phase
Aldara (imiquimod) Immune response modifier 3M Pharmaceuticals III
Pen 203 Antiproliferative agent CoPharma II (basal cell)
Photodynamic therapy with verteporfin Phototherapy Novartis III (basal cell)
For more information contact us at clinicaltrials@cancerconsultants.com

View Drugs in Pipeline By Disease



© 1998-2007 CancerConsultants.com  All Rights Reserved.